tiprankstipranks

Analyst Profile

Followed by 312 followers
.
Robert Burns

Robert Burns

H.C. Wainwright
Wall Street Analyst
#7,814 out of 7,963 Wall Street Analysts
#21,742 out of 22,261 experts

Success Rate

22%
85 out of 394 transactions made a profit

Average Return

-22.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Robert Burns's trades since 2020 and holding each position for 1 Year would result in 21.57% of your transactions generating a profit, with an average return of -22.5% per rating.

Stock Rating Distribution

542Ratings
89.30% Buy
10.70% Hold
0.00% Sell
Distribution of Robert Burns's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Immunomedics
(IMMU)
Rating:Buy
Date:Apr 02, 2020 - Sep 14, 2020
Return:+685.40%
The most profitable rating made by Robert Burns

Robert Burns's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
NTGN
Neon Therapeutics
Jan 21, 2020
Hold
Reiterated
1Ratings
0.00%
IMMU
Immunomedics
Sep 14, 2020
Hold
Downgraded
13Ratings
100%
+269.03%
Nucana
Mar 05, 2021
Buy
Reiterated
$10.00
(900.00% Upside)
8Ratings
0%
-48.07%
Molecular Partners
Aug 09, 2021
Buy
Reiterated
$25.00
(295.57% Upside)
2Ratings
0%
-64.50%
CytomX Therapeutics
May 10, 2022
Buy
Reiterated
$11.00
(653.42% Upside)
15Ratings
17%
-32.73%
TPTX
Turning Point Therapeutics
Jun 06, 2022
Hold
Downgraded
$76.00
(-0.01% Downside)
29Ratings
57%
+24.57%
Nurix Therapeutics
Jul 11, 2022
Buy
Reiterated
$54.00
(291.87% Upside)
4Ratings
0%
-28.77%
Repare Therapeutics
Aug 09, 2022
Buy
Reiterated
$38.00
(207.94% Upside)
9Ratings
25%
-15.53%
Kronos Bio
Aug 09, 2022
Buy
Reiterated
$36.00
(865.15% Upside)
8Ratings
0%
-58.96%
Zymeworks
Aug 09, 2022
Buy
Reiterated
$40.00
(616.85% Upside)
8Ratings
0%
-52.57%
List of latest recommendations made by Robert Burns. Click to expand and see Robert Burns's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >